TCBWMS
NRXP icon

Texas Capital Bank Wealth Management Services’s NRX Pharmaceuticals NRXP Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,329
Closed -$29.9K – 211
2024
Q1 		$29.9K Hold
6,329
– – ﹤0.01% 194
2023
Q4 		$29.1K Hold
6,329
– – ﹤0.01% 202
2023
Q3 		$16.5K Hold
6,329
– – ﹤0.01% 209
2023
Q2 		$30.6K Hold
6,329
– – ﹤0.01% 224
2023
Q1 		$41.7K Hold
6,329
– – ﹤0.01% 186
2022
Q4 		$70.3K Hold
6,329
– – 0.01% 164
2022
Q3 		$47K Buy
+6,329
New +$42.7K 0.01% 146

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OWMIAS
One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's NRXP Position: Q2 2024 in Review

Texas Capital Bank Wealth Management Services sold out of NRX Pharmaceuticals (NRXP) in Q2 2024, closing a stake of 6,329 shares — an estimated $29.9K sold.

Texas Capital Bank Wealth Management Services first reported a position in NRXP in Q3 2022 and held it in 7 quarters. The position peaked at $70.3K in Q4 2022. 19 funds tracked by Wall St. Rank hold NRXP as of Q2 2024.

  • Texas Capital Bank Wealth Management Services reported no remaining NRX Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Texas Capital Bank Wealth Management Services sold 6,329 NRX Pharmaceuticals shares in Q2 2024, an estimated $29.9K.
  • Texas Capital Bank Wealth Management Services first reported a position in NRX Pharmaceuticals in Q3 2022 and held it in 7 quarters.
  • Texas Capital Bank Wealth Management Services's NRX Pharmaceuticals position peaked at $70.3K in Q4 2022.
  • 19 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2024.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q2 2024, filed 15 Aug 2024.